MICHAEL GALEN GIBBS

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology SANTA BARBARA, CA NPI 1063704641

General Payments — all program years on this page

$2,275.36

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $569.00 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $569.0021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $307.616
2019 $289.349
2020 $29.201
2021 $53.153
2022 $488.229
2023 $538.8420
2024 $569.0021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103794857 ABBVIE INC. $18.05 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103794859 ABBVIE INC. $14.40 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103794861 ABBVIE INC. $19.11 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103794863 ABBVIE INC. $18.92 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103794865 ABBVIE INC. $14.99 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104805607 Biogen, Inc. $13.88 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104806747 Biogen, Inc. $16.57 07/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104829210 Biogen, Inc. $14.50 03/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104855718 Biogen, Inc. $15.89 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120236950 EMD Serono, Inc. $24.96 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143147949 UCB, Inc. $21.75 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144446360 CATALYST PHARMACEUTICALS, INC. $26.84 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144446362 CATALYST PHARMACEUTICALS, INC. $22.43 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145642090 Neurelis, Inc. $42.66 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145642092 Neurelis, Inc. $33.97 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148855763 Sumitomo Pharma America, Inc. $23.00 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148855765 Sumitomo Pharma America, Inc. $13.59 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150197906 JAZZ PHARMACEUTICALS INC. $23.09 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154143678 SK Life Science, Inc. $27.38 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154143680 SK Life Science, Inc. $1.33 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154143802 SK Life Science, Inc. $161.69 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.